NCT06879041
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06879041
Title A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Research Site NOT_YET_RECRUITING Palo Alto California 94304 United States Details
Research Site RECRUITING Miami Florida 33165 United States Details
Research Site RECRUITING Tampa Florida 33612 United States Details
Research Site RECRUITING Chicago Illinois 60637 United States Details
Research Site NOT_YET_RECRUITING Metairie Louisiana 70006 United States Details
Research Site RECRUITING Boston Massachusetts 02215 United States Details
Research Site NOT_YET_RECRUITING Rochester Minnesota 55902 United States Details
Research Site RECRUITING Omaha Nebraska 68130 United States Details
Research Site NOT_YET_RECRUITING New York New York 10032 United States Details
Research Site NOT_YET_RECRUITING Cleveland Ohio 44195 United States Details
Research Site NOT_YET_RECRUITING Portland Oregon 97239 United States Details
Research Site RECRUITING East Melbourne 3002 Australia Details
Research Site NOT_YET_RECRUITING CapeTown 7925 South Africa Details
Research Site WITHDRAWN Durban 4013 South Africa Details
Research Site NOT_YET_RECRUITING Pretoria 181 South Africa Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field